Form 8-K - Current report:
SEC Accession No. 0001213900-17-010419
Filing Date
2017-10-10
Accepted
2017-10-10 14:43:29
Documents
1
Period of Report
2017-10-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k100917_dandritbiotech.htm 8-K 16905
  Complete submission text file 0001213900-17-010419.txt   18137
Mailing Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7
Business Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7 45 39179840
DanDrit Biotech USA, Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54478 | Film No.: 171130131
SIC: 2834 Pharmaceutical Preparations